100 related articles for article (PubMed ID: 25123305)
1. The pathology of bowel cancer screening.
Loughrey MB; Shepherd NA
Histopathology; 2015 Jan; 66(1):66-77. PubMed ID: 25123305
[TBL] [Abstract][Full Text] [Related]
2. Challenging diagnostic issues in adenomatous polyps with epithelial misplacement in bowel cancer screening: 5 years' experience of the Bowel Cancer Screening Programme Expert Board.
Griggs RK; Novelli MR; Sanders DS; Warren BF; Williams GT; Quirke P; Shepherd NA
Histopathology; 2017 Feb; 70(3):466-472. PubMed ID: 27676454
[TBL] [Abstract][Full Text] [Related]
3. Bowel cancer screening-generated diagnostic conundrum of the century: pseudoinvasion in sigmoid colonic polyps.
Shepherd NA; Griggs RK
Mod Pathol; 2015 Jan; 28 Suppl 1():S88-94. PubMed ID: 25560603
[TBL] [Abstract][Full Text] [Related]
4. Interobserver agreement in the reporting of colorectal polyp pathology among bowel cancer screening pathologists in Wales.
Turner JK; Williams GT; Morgan M; Wright M; Dolwani S
Histopathology; 2013 May; 62(6):916-24. PubMed ID: 23611360
[TBL] [Abstract][Full Text] [Related]
5. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Quality assurance in pathology in colorectal cancer screening and diagnosis.
Quirke P; Risio M; Lambert R; von Karsa L; Vieth M;
Endoscopy; 2012 Sep; 44 Suppl 3():SE116-30. PubMed ID: 23012115
[TBL] [Abstract][Full Text] [Related]
6. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.
Nishida H; Urano S
Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345
[TBL] [Abstract][Full Text] [Related]
8. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Management of lesions detected in colorectal cancer screening.
Steele RJ; Pox C; Kuipers EJ; Minoli G; Lambert R;
Endoscopy; 2012 Sep; 44 Suppl 3():SE140-50. PubMed ID: 23012117
[TBL] [Abstract][Full Text] [Related]
9. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of colorectal cancer in individuals with serrated polyps.
Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
[TBL] [Abstract][Full Text] [Related]
11. Recommended intervals between screening and surveillance colonoscopies.
Baron TH; Smyrk TC; Rex DK
Mayo Clin Proc; 2013 Aug; 88(8):854-8. PubMed ID: 23910411
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
Nakama H; Fukazawa K
Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
[TBL] [Abstract][Full Text] [Related]
13. [Colorectal cancer: study on 365 cases].
Celestino A; Castillo T; Frisancho O; Contardo C; Espejo H; Tomioka C; Navarrete J
Rev Gastroenterol Peru; 1996; 16(3):187-96. PubMed ID: 12165782
[TBL] [Abstract][Full Text] [Related]
14. Infrared Spectroscopic Analysis in the Differentiation of Epithelial Misplacement From Adenocarcinoma in Sigmoid Colonic Adenomatous Polyps.
Nallala J; Griggs R; Lloyd GR; Stone N; Shepherd NA
Clin Pathol; 2022; 15():2632010X221088960. PubMed ID: 35509812
[TBL] [Abstract][Full Text] [Related]
15. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Colonoscopic surveillance following adenoma removal.
Atkin WS; Valori R; Kuipers EJ; Hoff G; Senore C; Segnan N; Jover R; Schmiegel W; Lambert R; Pox C;
Endoscopy; 2012 Sep; 44 Suppl 3():SE151-63. PubMed ID: 23012119
[TBL] [Abstract][Full Text] [Related]
16. Serrated polyp detection rate during screening colonoscopy.
Liang J; Kalady MF; Appau K; Church J
Colorectal Dis; 2012 Nov; 14(11):1323-7. PubMed ID: 22390284
[TBL] [Abstract][Full Text] [Related]
17. [Serrated, hyperplastic and hyperplasia-like colorectal polyps].
Folker MB; Bernstein IT; Holck S
Ugeskr Laeger; 2006 Nov; 168(46):4005-9. PubMed ID: 17125655
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of immunochemical fecal occult blood test for small colorectal neoplasms.
Abdul Fattah AS; Nakama H; Zhang B; Uehara Y; Kamijo N; Fujimori K
Eur J Med Res; 1997 May; 2(5):227-30. PubMed ID: 9153349
[TBL] [Abstract][Full Text] [Related]
19. Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance.
East JE; Vieth M; Rex DK
Gut; 2015 Jun; 64(6):991-1000. PubMed ID: 25748647
[No Abstract] [Full Text] [Related]
20. Pathways of carcinogenesis are reflected in patterns of polyp pathology in patients screened for colorectal cancer.
Costedio M; Church J
Dis Colon Rectum; 2011 Oct; 54(10):1224-8. PubMed ID: 21904136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
